Cytomx Therapeutics Inc Stock Performance
as on September 13, 2025 at 1:29 am IST
Day's High
$2$2.15.00%
Upside
52 Week's Low
52 Week's High
$0.4$3.1
80.00%
Downside
54.75%
Upside
Cytomx Therapeutics Inc share price movements today
- Previous Close
- $2.09
- Open
- $2.09
- Volume
- 1.9M
- Day's Low - High
- $2 - $2.1
- 52 Week Low - High
- $0.4 - $3.1
Cytomx Therapeutics Inc Historical Returns
- 1 Month Return
- + 4.71 %
- 3 Month Return
- -27.27 %
- 1 Year Return
- + 62.6 %
- 3 Year Return
- + 20.48 %
- 5 Year Return
- -72.3 %
Cytomx Therapeutics Inc Stock Fundamentals & Key Indicators
Check Cytomx Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$329.8M
EPS (TTM)
0.074
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.61%
PE Ratio (TTM)
4
Industry PE ratio
-3.8535542168674697
P/B Ratio
4
PEG Ratio
-1.8
EBITDA
44.7M
Revenue (TTM)
141.1M
Profit Margin
34.01%
Return On Equity TTM
108.21%
Cytomx Therapeutics Inc Stock Valuation
Track how Cytomx Therapeutics Inc P/E has moved over time to understand its valuation trends.
Cytomx Therapeutics Inc in the last 5 years
Lowest (1.58x)
March 31, 2025
Industry (-3.85x)
September 15, 2025
Today (4.00x)
September 15, 2025
Highest (14.22x)
June 30, 2024
Today’s Price to Earnings Ratio: 4.00x
Cytomx Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cytomx Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $329.8M | -72.3% | 4 | 34.01% | |
| BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
| NA | $37.7B | NA | NA | -3.89% | |
| BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
| BUY | $59.4B | 2.03% | 14.11 | 31.37% |
Stock Returns calculator for Cytomx Therapeutics Inc Stock including INR - Dollar returns
The Cytomx Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cytomx Therapeutics Inc investment value today
Current value as on today
₹1,67,741
Returns
₹67,741
(+67.74%)
Returns from Cytomx Therapeutics Inc Stock
₹62,602 (+62.6%)
Dollar Returns*
₹5,139 (+5.14%)
Analyst Recommendation on Cytomx Therapeutics Inc Stock
Based on 13 analysts
46.15%
Buy
53.85%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'HOLD' rating for Cytomx Therapeutics Inc. Average target price of $5.75
Cytomx Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Cytomx Therapeutics Inc.
What analysts predicted
65.22%UPSIDE
Target Price
$5.75
Current Price
$2
Analyzed by
13 Analysts
Target
$5.75
Cytomx Therapeutics Inc target price $5.75, a slight upside of 65.22% compared to current price of $2. According to 13 analysts rating.
Cytomx Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Cytomx Therapeutics Inc Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Cytomx Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Cytomx Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Cytomx Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Cytomx Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Cytomx Therapeutics Inc
Insights on Cytomx Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 13.0%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 103.0%
NEGATIVE IMPACTPrice Dip
In the last 7 days, CTMX stock has moved down by -8.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 23.52M → -154.0K (in $), with an average decrease of 100.7% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 50.91M → 18.65M (in $), with an average decrease of 63.4% per quarter
About Cytomx Therapeutics Inc
| Organisation | Cytomx Therapeutics Inc |
| Headquarters | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Sean A. McCarthy DPHIL |
| E-voting on shares | Click here to vote |
Key Management of Cytomx Therapeutics Inc
Name | Title |
|---|---|
Dr. Sean A. McCarthy DPHIL | Chairman & CEO |
Mr. Christopher W. Ogden | SVP & Chief Financial Officer |
Dr. Marcia P. Belvin Ph.D. | Senior VP & Chief Scientific Officer |
Ms. Leslie Robbins J.D. | Senior Vice President of Intellectual Property |
Dr. Stephanie Robertson Ph.D. | Senior Vice President of Alliances & Program Leadership |
Dr. Yu-Waye Chu M.D. | Chief Medical Officer |
Mr. Lloyd A. Rowland Jr., J.D. | Senior VP, General Counsel, Chief Compliance Officer & Secretary |
Ms. Danielle Olander-Moghadassian | Senior VP & Chief Human Resources Officer |
Ms. Dawn Benson | Senior Vice President of Quality & Product Manufacturing |
FAQs
What is Cytomx Therapeutics Inc share price today?
Cytomx Therapeutics Inc share price today is $2 as on at the close of the market. Cytomx Therapeutics Inc share today touched a day high of $2.1 and a low of $2.
What is the 52 week high and 52 week low for Cytomx Therapeutics Inc share?
Cytomx Therapeutics Inc share touched a 52 week high of $3.1 on and a 52 week low of $0.4 on . Cytomx Therapeutics Inc stock price today i.e. is closed at $2,which is 35.38% down from its 52 week high and 400.00% up from its 52 week low.
What is Cytomx Therapeutics Inc's market capitalisation today?
Cytomx Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Cytomx Therapeutics Inc Stock (CTMX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cytomx Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytomx Therapeutics Inc Shares that will get you 0.7500 shares as per Cytomx Therapeutics Inc share price of $2 per share as on September 13, 2025 at 1:29 am IST.
What is the minimum amount required to buy Cytomx Therapeutics Inc Stock (CTMX) from India?
Indian investors can start investing in Cytomx Therapeutics Inc (CTMX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Cytomx Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cytomx Therapeutics Inc share’s latest price of $2 as on September 13, 2025 at 1:29 am IST, you will get 5.0000 shares of Cytomx Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Cytomx Therapeutics Inc has given to Indian investors in the last 5 years?
Cytomx Therapeutics Inc stock has given -72.3% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?